Pharma.Aero drew roughly half of its participants back for a second or further year as it staged its sixth Pharma Logistic Masterclass in Frankfurt, part of the association's 10-year anniversary programme — a retention rate that suggests senior pharma logistics executives see real operational value in a format built on shared problem-solving rather than podium presentations.

The Brussels-based organisation, which connects Life Science and MedTech manufacturers with logistics providers across air, land and sea, designed the event to move beyond conventional conference sessions. Morning expert presentations gave way to afternoon workshops organised around C-suite perspectives, with participants asked to test what the ideas mean once they reach a boardroom or an operational decision.

Group sizes are capped at 30 to stop the workshops turning into passive listening exercises and to force discussion, challenge and joint problem-solving.

What does the format change?

"A lot of people think I know it all and my knowledge is my possession, but your knowledge is only meaningful if you share it, and that's what the Masterclass is all about," Pharma.Aero Secretary General Frank Van Gelder said. "What we see here is a group of pretty executive-level, senior VPs, VPs, professors, CEO level, C level and top senior consultants that actually come together in our community. We then share the knowledge we can offer them."

For shippers of temperature-sensitive, highly regulated healthcare products, the commercial relevance is straightforward. The fundamentals of moving those goods remain familiar, but the operating environment — geopolitical disruption, technological change and increasingly complex products — does not. A platform that stress-tests ideas such as AI and digital twins against operational reality before they are adopted has direct cost and risk implications for cold-chain decision-making.

Van Gelder pointed to how quickly the agenda itself has shifted. "Technology is an important element. Digital twinning, six years ago we were not speaking about that, and AI is all over the place now. These are things that I would say are the seasoning of the Masterclass programme," he explained.

Where business meets academia

Academic partnerships sit at the centre of the programme. Pharma.Aero pairs each edition with at least two universities and two academic sites focused on pharma logistics, on the argument that neither industry nor academia holds all the answers to increasingly complicated supply-chain problems. Operators bring exposure to commercial and regulatory pressure; universities contribute research capability and analytical frameworks.

"There is a lot behind that slogan, because especially from the educational side and the academic side, we realise that we don't know it all. The exchange between different professors and different academic programmes is absolutely necessary to get the right flavour," Van Gelder outlined.

Location is chosen deliberately. Previous editions ran in Kyoto and Osaka, and the next edition moves to Hong Kong — a choice driven by the strength of the local Pharma.Aero community, the availability of a strategic airport partner, university collaboration and the relevance of the surrounding market.

The rotating geography exposes participants to different logistics ecosystems and regional priorities while keeping the focus fixed on pharmaceutical supply chains — useful exposure for forwarders and carriers whose pharma customers increasingly demand lane-level visibility across modes.

Why the curriculum never stands still

Rather than following a fixed curriculum, the organising committee rebuilds the content each year around developments from the previous six to twelve months. That approach keeps the programme aligned with what has actually tested pharma supply chains — regulatory shifts, capacity shocks and technology adoption — rather than recycling case studies.

"We learn every year, and that's the challenge for the organising committee: what are we bringing new? There is so much happening in the world that every year we can really adapt to what we went through in the past six months to a year. Being actual, being new to the things that happen is bringing knowledge," Van Gelder concluded.

With the Hong Kong edition next in line, and AI and digital twins now embedded in the mainstream conversation rather than the emerging-concept fringe, the Masterclass format looks set to keep converting cross-industry dialogue into boardroom-ready practice for pharma supply chains under pressure.